Answers are grounded in this paper and cite their sources.
Nitrofurantoin has shown exceptional durability against resistance over 70 years of use. This longevity stems from factors such as rapid achievement of therapeutic concentrations, multiple physiological targets against bacteria, low risk of horizontal gene transfer, and the need to acquire multiple mutations to achieve resistance. These combined features limit resistance emergence and spread of nitrofurantoin resistance. We propose nitrofurantoin as an exemplar for developing other durable treatments.
No takes yet. Share an insight, caveat, or question.
Kettlewell et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: